About 30,920 results

ALLMedicine™ Cystic Fibrosis Center

Research & Reviews  10,143 results

A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years ...
American Journal of Respiratory and Critical Care Medicine; Rayment JH, Asfour F et. al.

Jul 1st, 2022 - Previous phase 3 trials showed treatment with lumacaftor/ivacaftor was safe and efficacious in people aged ≥2 years with cystic fibrosis homozygous for F508del-CFTR (F/F genotype). To assess the safety, pharmacokinetics, and pharmacodynamics of lu...

Behavioral Health Screening in Military Cystic Fibrosis Centers: A Survey.
Military Medicine; Rutledge C, Gould C et. al.

Jul 1st, 2022 - Cystic fibrosis (CF) is the most common life-threatening genetic illness in the United States. People with CF as well as their caregivers are up to three times more likely to report experiencing symptoms of depression and anxiety than those withou...

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.
Journal of Cystic Fibrosis : Official Journal of the Euro... Ronan NJ, Einarsson GG et. al.

Jun 29th, 2022 - Cystic Fibrosis (CF) has prominent gastrointestinal and pancreatic manifestations. The aim of this study was to determine the effect of Cystic fibrosis transmembrane conductance regulator (CFTR) modulation on, gastrointestinal inflammation, pancre...

Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2021.
American Journal of Physiology. Lung Cellular and Molecul... Ikonomou L, Magnusson M et. al.

Jun 29th, 2022 - The 9th biennial conference titled "Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases" was hosted virtually, due to the ongoing COVID-19 pandemic, in collaboration with the University of Vermont Larner College of Medicine...

Collaboration Between Two CF Centers; one in USA and one in Turkey before and during Co...
Pediatric Pulmonology; Nasr SZ, Gökdemir Y et. al.

Jun 28th, 2022 - To address the discrepancy in quality of care and outcomes between cystic fibrosis centers (CFC) in high income countries and limited resources countries (LRC), a collaboration between our team at the University of Michigan CFC (UMCFC) and a CF ce...

see more →

Guidelines  31 results

Non-invasive diagnosis and follow-up of rare genetic liver diseases.
Clinics and Research in Hepatology and Gastroenterology; Sobesky R, Guillaud O et. al.

Aug 1st, 2021 - Rare genetic liver diseases can result in multi-systemic damage, which may compromise the patient's prognosis. Wilson's disease and alpha-1 antitrypsin deficiency must be investigated in any patient with unexplained liver disease. Cystic fibrosis ...

Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of is...
American Journal of Obstetrics and Gynecology; , Prabhu M et. al.

Jun 26th, 2021 - Soft markers were originally introduced to prenatal ultrasonography to improve the detection of trisomy 21 over that achievable with age-based and serum screening strategies. As prenatal genetic screening strategies have greatly evolved in the las...

Models of Palliative Care Delivery for Individuals with Cystic Fibrosis: Cystic Fibrosi...
Journal of Palliative Medicine; Kavalieratos D, Georgiopoulos AM et. al.

Sep 17th, 2020 - Cystic fibrosis (CF) affects more than 70,000 individuals and their families worldwide. Although outcomes for individuals with CF continue to improve, it remains a life-limiting condition with no cure. Individuals with CF manage extensive symptom ...

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID...
Clinical Infectious Diseases : an Official Publication Of... Daley CL, Iaccarino JM et. al.

Aug 17th, 2020 - Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (wit...

Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID...
The European Respiratory Journal; Daley CL, Iaccarino JM et. al.

Jul 9th, 2020 - Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (wit...

see more →

Drugs  140 results see all →

Clinicaltrials.gov  1,436 results

Natural History of Bronchiectasis

Jun 24th, 2022 - Bronchiectasis, or abnormal dilation of the airways, is a condition typically characterized by chronic and recurring respiratory tract infections. Frequently, depending on the underlying cause, these infections involve the entire respiratory tract...

Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease

Jun 24th, 2022 - Background: Nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms that have been increasingly associated with human disease, commonly involving the lung. Post menopausal Caucasian women seem particularly predisposed to the devel...

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

Jun 24th, 2022 - This study will be a prospective, longitudinal, observational, single-center, exploratory, natural history study to collect samples and data that will enable prospective explorations of the interaction between environmental exposures and disease p...

Natural History of Noncirrhotic Portal Hypertension

Jun 24th, 2022 - Noncirrhotic Portal Hypertension (NCPH) includes a spectrum of chronic liver diseases characterized by increased pressure within the portal circulation in the absence of cirrhosis. The complications from NCPH are similar to that of cirrhosis induc...

Diagnosis and Treatment of Patients With Cystic Fibrosis

Jun 24th, 2022 - This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical ma...

see more →

News  580 results

Eosinophilic Diseases Often Overlap, Raising Costs

May 27th, 2022 - Eosinophilic GI diseases (EGIDs) often overlap with other eosinophil-associated diseases (EADs), which leads to greater health care costs, according to an analysis of the U.S. Optum Clinformatics claims database. EADs have gained increased attenti...

Eosinophilic diseases often overlap, raising costs
Jim Kling

May 26th, 2022 - Eosinophilic GI diseases (EGIDs) often overlap with other eosinophil-associated diseases (EADs), which leads to greater health care costs, according to an analysis of the U. S.

Elevated Eosinophils Linked to Respiratory Symptoms in Cystic Fibrosis

Apr 21st, 2022 - Patients with cystic fibrosis (CF) and elevated blood eosinophil counts had significantly increased respiratory symptoms compared to those with lower eosinophil counts, based on data from 109 individuals. Elevated blood eosinophil counts have been...

Nontuberculous Mycobacterial Lung Disease Can Be Challenging to Treat

Apr 12th, 2022 - Living in coastal areas of Florida and California has great appeal for many, with the warm, sunny climate and nearby freshwater and saltwater. But, unknown to many, those balmy coasts also carry the risk of infection from nontuberculous (atypical)...

Exocrine Pancreatic Insufficiency: Clinical Presentation and Diagnosis
Darshan Kothari, MD, MDedge News

Apr 1st, 2022 - Darshan Kothari, MD is an assistant professor at Duke University School of Medicine and at the Durham Veteran’s Affairs Medical Center where he serves as the director of the Pancreas Program. He received his MD from Stony Brook University Medical.

see more →

Patient Education  38 results see all →